PTPN23 Overexpression Is Associated with Reduced Proliferation and Tumor Growth in Murine Models of Colorectal Cancer
International Journal of Molecular Sciences · 2026
DOI: 10.3390/ijms27177955 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2026. Verfasst von Rocio Sanchez Alvarez und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterology and Hepatology, University Hospital Zurich, University of Zurich, 8091 Zurich, Switzerland. Hauptthemen laut MEDLINE: Colorectal Neoplasms, Protein Tyrosine Phosphatases, Non-Receptor. Die Arbeit nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: University of Zurich, Swiss National Science Foundation, Universität Zürich.
Abstract (Originalsprache)
Protein tyrosine phosphatases (PTPs) are key regulators of intracellular signaling cascades involved in cell growth, proliferation, differentiation, inflammation, and cancer. PTPN23, a non-receptor PTP, is involved in endosomal sorting and thereby regulates the internalization of growth factor receptors, such as the epidermal growth factor receptor (EGFR). PTPN23 has been proposed to exert tumor-suppressive effects in several epithelial cancers, including breast and lung cancer. PTPN23 is ubiquitously expressed in the body; however, it is particularly highly expressed in the intestine, where it plays an essential role in maintaining intestinal homeostasis. Despite these observations, its involvement in colorectal carcinoma (CRC) remains largely unexplored. To investigate the function of PTPN23 in CRC, we generated PTPN23-overexpressing CRC cell lines and evaluated their effects in vitro and in subcutaneous tumor models. Our in-vitro findings demonstrate that PTPN23 overexpression resulted in reduced proliferation levels and follow-up experiments showed suppression of colorectal cancer growth and proliferation in experimental CRC models. These effects were accompanied by changes in EGFR-associated signaling; however, the underlying mechanism, including a potential role of EGFR trafficking, remains to be established through direct experimental validation. Together, these findings expand current knowledge of PTPN23 in colorectal cancer and provide a basis for future studies addressing its biological function and therapeutic relevance.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Gastroenterology and Hepatology, University Hospital Zurich, University of Zurich, 8091 Zurich, Switzerland.
- Institute of Molecular Cancer Research, University of Zurich, 8057 Zurich, Switzerland.
ORCID-Profile: Rocio Sanchez Alvarez, Claudia Gottier, Ana Montalban-Arques, Anna Bircher, Doris Pöhlmann, Marlene Schwarzfischer, Silvia Lang, Marianne R Spalinger
Förderung
- University of Zurich
- Swiss National Science Foundation
- Universität Zürich
- SNSF
- Julius-Müller Foundation
Zitieren
APA
Sanchez Alvarez, R., Gottier, C., Montalban-Arques, A., Bircher, A., Pöhlmann, D., Schwarzfischer, M., Müller, A., Lang, S., Spalinger, M. R., & Scharl, M. (2026). PTPN23 Overexpression Is Associated with Reduced Proliferation and Tumor Growth in Murine Models of Colorectal Cancer. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms27177955
Vancouver
Sanchez Alvarez R, Gottier C, Montalban-Arques A, Bircher A, Pöhlmann D, Schwarzfischer M, et al. PTPN23 Overexpression Is Associated with Reduced Proliferation and Tumor Growth in Murine Models of Colorectal Cancer. International Journal of Molecular Sciences. 2026. doi:10.3390/ijms27177955
BibTeX
@article{SanchezAlvarez2026,
author = {Sanchez Alvarez, Rocio and Gottier, Claudia and Montalban-Arques, Ana and Bircher, Anna and Pöhlmann, Doris and Schwarzfischer, Marlene and Müller, Anne and Lang, Silvia and Spalinger, Marianne R and Scharl, Michael},
title = {PTPN23 Overexpression Is Associated with Reduced Proliferation and Tumor Growth in Murine Models of Colorectal Cancer},
journal = {International Journal of Molecular Sciences},
year = {2026},
doi = {10.3390/ijms27177955}
}
EUVIMED